A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
Clinical trial NCT01628926 · COMPLETED
Trial details
- NCT number
- NCT01628926
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-05-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.